Late-stage kidney disease patients have to rely on hemodialysis for the maintenance of their regular lives. Arteriovenous graft (AVG) is one of the commonly used devices for dialysis. However, this artificially created shunt may get clotted and eventually causes the dialysis to fail. The culprit behind the AVG clotting and failure is the intimal hyperplasia (IH), the gradual thickening of vein-wall in the vicinity of the blood vessel-graft conjunctions. The mechanism of IH is not well understood despite extensive studies. In this work, we investigate the effects of the IH development, including its location and severity on the flow and force fields in the distal AVG anastomosis using computational fluid dynamics. The stenosis due to IH is m...
A diseased artery often becomes blocked, compromising blood flow to downstream tissues and organs. O...
Arterio-venous fistulae (AVF) are surgically created vascular connections between an artery and a ve...
The major cause of arterial bypass graft failure is intimal hyperplasia. Fluctuating wall shear stre...
Patients with end-stage renal disease are usually treated by hemodialysis while waiting for a kidney...
Hemodialysis is a common treatment for end-stage renal-disease patients to manage their renal failur...
Objective: Arteriovenous grafts (AVGs) typically lose patency within two years of creation due to ve...
With the advent of using an arteriovenous fistula for hemodialysis, the anastomosis built for such u...
Hemodialysis is a common treatment for ESRD patients to manage their chronic renal failure while awa...
Hemodialysis is a common treatment for ESRD patients to manage their chronic renal failure while awa...
Although arterio-venous grafts (AVGs) represent the second choice as permanent vascular access forhe...
Click on the DOI link below to access the article(may not be free)A potential interaction between th...
The flow rate inside arteriovenous fistulas is many times higher than physiological flow and is acco...
Although arterio-venous grafts (AVGs) are the second best option as permanent vascular access for he...
Objective The hemodynamic benefit of novel arteriovenous graft (AVG) designs is typically assessed u...
A diseased artery often becomes blocked, compromising blood flow to downstream tissues and organs. O...
Arterio-venous fistulae (AVF) are surgically created vascular connections between an artery and a ve...
The major cause of arterial bypass graft failure is intimal hyperplasia. Fluctuating wall shear stre...
Patients with end-stage renal disease are usually treated by hemodialysis while waiting for a kidney...
Hemodialysis is a common treatment for end-stage renal-disease patients to manage their renal failur...
Objective: Arteriovenous grafts (AVGs) typically lose patency within two years of creation due to ve...
With the advent of using an arteriovenous fistula for hemodialysis, the anastomosis built for such u...
Hemodialysis is a common treatment for ESRD patients to manage their chronic renal failure while awa...
Hemodialysis is a common treatment for ESRD patients to manage their chronic renal failure while awa...
Although arterio-venous grafts (AVGs) represent the second choice as permanent vascular access forhe...
Click on the DOI link below to access the article(may not be free)A potential interaction between th...
The flow rate inside arteriovenous fistulas is many times higher than physiological flow and is acco...
Although arterio-venous grafts (AVGs) are the second best option as permanent vascular access for he...
Objective The hemodynamic benefit of novel arteriovenous graft (AVG) designs is typically assessed u...
A diseased artery often becomes blocked, compromising blood flow to downstream tissues and organs. O...
Arterio-venous fistulae (AVF) are surgically created vascular connections between an artery and a ve...
The major cause of arterial bypass graft failure is intimal hyperplasia. Fluctuating wall shear stre...